Q2 2025 Earnings Call Transcript August 11, 2025 Kymera Therapeutics, Inc. misses on earnings expectations. Reported EPS is $ ...

Phase 1 healthy volunteer data surpassing Kymera's target product profile, and further validating its oral, dupilumab-like profile KT-621 BroADen Phase 1b trial in ...

Phase 1 healthy volunteer data surpassing Kymera’s target product profile, and further validating its oral, dupilumab-like profile ...

Reviving soil health as a pathway to strengthening livelihood security and nutritious food in rural India Securing nutritional food for India’s 1.4 billion people requires urgent focus on ...

Exactly what could be different this time around remains unknown, but Jon Rahm offered some suggestions when he spoke with the media Wednesday at the LIV event in Chicago.

NICE and the Medicines and Healthcare products Regulatory Agency (MHRA) have described how the 10-Year Health Plan will lead to faster medicines access for patients in the NHS in England.

Pathways to Decarbonizing the Rail Industry Written by Alex Scott, Associate Professor of Supply Chain Management, University of Tennessee - Knoxville; Gerald T. Niedert Professor, Haslam College of ...

A class of drugs called androgen receptor pathway inhibitors (ARPIs) are often added to the treatment plan, alongside androgen deprivation therapy (ADT), for men diagnosed with metastatic prostate ...

Alaska approves 120-credit CPA pathway without governor’s signature: Trial Balance Alaska Gov. Mike Dunleavy, who has spent much of his career in education, chose not to sign or veto the state’s new ...

Byproducts from gut bacteria breaking down tryptophan, a dietary amino acid, can restore hormone-secreting gut cells reduced by obesity, a new study found. It opens the door to a natural, side ...

LONDON & NEW YORK, July 31, 2025--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today ...